Interaction Checker

Las cookies nos ayudan a ofrecer nuestros servicios. Al utilizar nuestros servicios, aceptas el uso de cookies. Más información

New comedications: monoclonal antibodies

Friday 16 September 2022

The following monoclonal antibodies have been added to the interaction checker:

  • Belantamab mafodotin - Cancer Therapies
  • Belimumab - Immunosuppressants
  • Bezlotoxumab - Antibacterials
  • Bimekizumab - Immunosuppressants
  • Brolucizumab - Other
  • Caplacizumab - Anticoagulant, Anti-platelet and Fibrinolytic
  • Cemiplimab - Cancer Therapies
  • Crizanlizumab - Other
  • Dinutuximab beta - Cancer Therapies
  • Durvalumab - Cancer Therapies
  • Elotuzumab - Cancer Therapies
  • Erenumab - Antimigraine Agents
  • Fremanezumab - Antimigraine Agents

More monoclonals will be added in due course.

SPONSORS
EDITORIAL SPONSORS
Awards and commendations
bma-foundation-for-medical-research british-medical-journal-2018 queens_aniversary_prize_2017 rcp-excellence-patient-care-awards-2017 building_better_healthcare_awards_2016